ArticleAmerican journal of human genetics2009

Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.

Youichi Tajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.